Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning
Launched by NEW YORK UNIVERSITY · Apr 6, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of brain stimulation might help with learning to produce new speech sounds. Participants will practice saying made-up words, and researchers will compare the effects of various stimulation methods on their speech abilities. These methods include using anodal or cathodal stimulation on specific parts of the brain related to speech and motor control, as well as a "sham" version that doesn’t provide any real stimulation. The goal is to understand whether stimulating certain brain areas is important for learning to speak more accurately, which could eventually help people with speech difficulties.
To participate, individuals need to be native English speakers who haven’t been exposed to certain other languages that include similar sounds. They should not have any history of speech, language, or hearing disorders and must pass a hearing test. Participants will engage in speech training sessions, and they will be monitored to see how well they learn to produce the new sounds. This study is a great opportunity for healthy adults aged 18 to 65 who meet the criteria and want to contribute to research that could benefit people with speech impairments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • native English speaker (learned English in the home from birth)
- • no exposure to languages that contain the trained consonant clusters (e.g., Slavic languages, Greek, Hebrew).
- Exclusion Criteria:
- • a history of speech, language or hearing disorder
- • not passing a hearing screening (40 dB HL; ANSI: 1983) at 500, 1000, 2000, 4000Hz binaurally
- • presence of potential tDCS risk factors: damaged skin at site of stimulation; presence of electrically or magnetically activated implant (including pacemaker); and metal in any part of their body
About New York University
New York University (NYU) is a prestigious research institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure and a diverse team of leading experts, NYU conducts cutting-edge research across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. The university fosters collaboration among multidisciplinary teams and engages with a broad patient population, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. NYU's dedication to excellence in research and education positions it as a key contributor to the advancement of healthcare and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Adam Buchwald, PhD
Principal Investigator
New York University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials